ENO1 and Patent ductus arteriosus: We have previously demonstrated that, in PDA patients, CT induces an antitumoral immune response, both in terms of antibody production and effector T lymphocyte response against four overexpressed PDA-associated TAA, namely ENO1, FUBP1, K2C8 and GAPDH (17).